The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
POLYOXYETHYLENE-80
TWEEN 80 is used in molecular biology with different applications...
PANAMutyper™ R EGFR
To screen EGFR+ patients and determine their response to various...
TBE – A00268
Total Product Size: 1000ml Individual Container Size: 1000ml Number of...